{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:26:16Z","timestamp":1762475176762,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jdcr.2020.05.023","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T19:23:19Z","timestamp":1590261799000},"page":"683-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis"],"prefix":"10.1016","volume":"6","author":[{"given":"Luis E.","family":"S\u00e1nchez-Due\u00f1as","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizet K.","family":"Rojano-Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jdcr.2020.05.023_bib1","doi-asserted-by":"crossref","first-page":"e12894","DOI":"10.1111\/dth.12894","article-title":"Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: a case of serendipity or zemblanity?","volume":"32","author":"Sacchelli","year":"2019","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jdcr.2020.05.023_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jdcr.2018.01.006","article-title":"Repigmentation and new growth of hairs after anti-interleukin-17 therapy with\u00a0secukinumab for psoriasis","volume":"4","author":"Rongioletti","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.jdcr.2020.05.023_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1067\/mjd.2003.100","article-title":"Hypertrichosis","volume":"48","author":"Wendelin","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2020.05.023_bib4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1365-2133.2008.08511.x","article-title":"Efalizumab-induced hypertrichosis","volume":"158","author":"Rallis","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2020.05.023_bib5","first-page":"49","article-title":"Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis","volume":"38","author":"Akarsu","year":"2013","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jdcr.2020.05.023_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jdcr.2020.05.023_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40257-014-0064-x","article-title":"Systemic therapies for psoriasis: an evidence-based update","volume":"15","author":"Sandoval","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdcr.2020.05.023_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/09546634.2013.879093","article-title":"The role of IL-17 in psoriasis","volume":"26","author":"Malakouti","year":"2015","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"10.1016\/j.jdcr.2020.05.023_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/ijd.14509","article-title":"Are new variants of psoriasis therapy (IL-17 inhibitors) safe?","volume":"58","author":"Wcis\u0142o-Dziadecka","year":"2019","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2020.05.023_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1684\/ejd.2018.3327","article-title":"Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration","volume":"28","author":"Mashima","year":"2018","journal-title":"Eur J Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620303842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620303842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:21:29Z","timestamp":1762474889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620303842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2352512620303842"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.05.023","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}